Insights
Read our latest posts focused on growing your practice and improving patient experience
Sign up for the Rendia Insider
Receive monthly update from experts in the field aimed to improve efficiency in your practice
Case Study: How Telehealth + Rendia = 10% Higher Conversions
COVID-19 changed this practice’s appointment model and patient education—for the better Like most eye care practices, Kugler Vision in...
Are Your Female Patients Aware of Their Increased Risk?
Many of your female patients may not be aware of their increased risk of eye and vision problems, or whether there’s anything they can do about it.
Rendia Has a New Website!
What we learned that could help your practice, too As you may have noticed, Rendia.com has a new look! When we decided our website was...
Market Your Practice By Thinking Like a Patient
The most effective practice marketing efforts start with thinking like a patient. What do they need? What do they want? Are you providing it? Do they know it? These are all important questions for every practice to consider.
The Expanded Affordable Care Act
What changes can medical practices, specifically eye care and ENT, expect to see in the Biden administration with the reopening of the ACA? Read on to find out.
Why Diversity Matters in Your Practice
Diversity has long been a buzzword in business and education, and it’s rapidly becoming an important issue in health care. Research...
March Is Save Your Vision Month
March is Save Your Vision Month, the perfect time to remind your patients and the public of the importance of eye health and comprehensive eye exams.
Are Patients Who Research Their Symptoms Online Better Informed?
Are these online information seekers better informed about their health? Are they finding high-quality information? The answers to those questions vary. Here’s how doctors can address this issue with their patients.
New Drug Approved for the Short-Term Treatment of Dry Eye Disease
The final FDA clinical trial met both of its primary efficacy endpoints, demonstrating a statistically significant improvement in the symptom endpoint of ocular discomfort after two weeks of treatment.